期刊文献+

CTL、NK及TIDC在胃腺癌组织中表达及对预后的影响

Expression of CTL and NK and TIDC in gastric adenocarcinoma and its infiltration with prognostic
原文传递
导出
摘要 目的研究CTL、NK及TIDC在胃腺癌组织中的分布情况及对病人生存与预后的影响。方法将CD8作为细胞毒T淋巴细胞(CTL)的标记物,CD56作为自然杀伤细胞(NK)的标记物,S-100作为肿瘤浸润树突状细胞(TIDC)的标记物,应用免疫组织化学方法检测肿瘤组织中CTL、NK及TIDC的分布和浸润情况。结果 80例胃腺癌中,CTL无-轻度浸润的48例,5年生存率为38%;显著浸润的32例,5年生存率为63%;NK细胞无-轻度浸润的50例,5年生存率42%,显著浸润的30例,5年生存率为63%;TIDC无-轻度浸润的52例,5年生存率为37%;TIDC显著浸润的28例,5年生存率为57%;NK/T及TIDC同时显著浸润的24例,5年生存率为67%;无-轻度浸润的32例,5年生存率为47%,经Log-rank检验,NK/T及TIDC显著浸润组和无-轻度浸润组的5年生存率差异有统计学意义(P=0.00)。结论胃腺癌组织中CTL、NK及TIDC显著浸润组的预后和生存时间明显好于轻度浸润组。 Objective To study the distribution and effect of CTL, NK and TIDC in gastric adenocareinoma patients on the survival and prognosis of the patient. Methods The distribution of the markers CD8, CD56 and S- 100 of cytoxic lymphocyte (CTL), natural killer (NK) and tumor Infiltrating dendritic cell (TIDC) in 80 patients with gastric adenocarcinoma were detected immunohistoehemieally. Results CTL infiltration in 48 gastric adenocareinoma patients was zero or mild with the five-year survival rate of 38%, while CTL infiltration was marked in 32 eases with the five-year survival rate of 63%. The NK infiltration in 50 gastric adenoeareinoma eases was zero or mild with the five-year survival rate of 42%, while the NK infiltration in 30 gastric adenocareinoma eases was marked with the five-year survival rate of 63%. TIDC infiltration in 50 gastric adenoeareinoma eases was zero or mild with the five-year survival rate of 37% , while it was marked in 28 gastric adenoeareinoma eases with the five-year survival rate of 57% .The CTL and the NK and the TIDC cells in 32 gastric adenoeareinoma cases were zero or mild with the five-year survival rate of 47%, while it was marked in 24 eases with the five- year survival rate of 67%.The five-year survival rates between marked and zero or mild infiltration groups were significantly different (P=0.0) by Log-rank test. Conclusion The prognosis and survival time of gastric adenoearcinoma eases with marked CTL, NK and TIDC infiltration were significantly better than that in mild infiltration group.
作者 李妹 龚选举
出处 《中国热带医学》 CAS 2015年第8期984-986,994,共4页 China Tropical Medicine
关键词 胃腺癌 免疫组织化学 免疫细胞 预后 Gastric adenoearcinoma Immunohistoehemistry Immune cell Prognosis
  • 相关文献

参考文献14

  • 1万亚锋,李兴睿,易继林.肿瘤细胞RNA转染活化的B细胞诱导的CTL抗肿瘤效应[J].中国普通外科杂志,2010,19(3):273-278. 被引量:2
  • 2郑玉军,王明吉.临床肿瘤免疫的研究近况[J].医学与哲学(B),2014,35(3):61-65. 被引量:1
  • 3Chen D S.Mellman I.Oncology meets immunology:the cancer-immunity cycle[J].Immunity,2013,39(1):1-10.
  • 4Hanahan D,Weinberg R A.Hallmarks of cancer; the next generation[J].Cell,2011,144(5):646-674.
  • 5Wakabayashi O,Yamazaki K,Oizumi S,et al.CD4(+)T cells in cancer stroma,not CD8(+)T cells in cancer cell nests,are associated with favorable prognosis in human non-small cell lung[J].cancer sci,2003,94(11):1003-1009.
  • 6Villegas FR,Coca S,Villarrubia VG,et al.Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer[J].Lung Cancer,2002,35(1):23-28.
  • 7Furukawa T,Watanabe S,Kodama T,et al.T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis[J].Cancer,1985,56:2651-2657.
  • 8Mami-Chouaib F,Ech chakir H,Dorothee G,et al.Antitumor cytotoxic T-lymphocyte response in human lung carcinoma:identification of a tumor-associated antigen[J].Immunol Rev,2002,188:114-121.
  • 9Tsujitani S,Kakeji Y,Watanabe A,et al.Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer[J].Cancer,1990,66:2012-2016.
  • 10Fietta P,Delsante G.Focus on human natural kills[J].RivBiol,2009,102(2):219-235.

二级参考文献32

  • 1Hamid O, Robert C, Daud A, eta|. Safety and tumor responses with lamhrolizumab (anti-PD-1) in melanomal-J~. N Engl J Med, 2013, 369(2) :134-144.
  • 2Hodi F S,(YDay S J, McDermott D F, et al. Improved survival with ipilimumab in patients with metastatic melanoma[J]. N Engl JMed,2010,363(8) :711-723.
  • 3Topalian S L,Hodi F S,Brahmer J R,et al. Safety,activity,and im mune correlates of anti-PD-1 antibody in cancer[J]. N Engl J Med, 2012,366(26):2443 2454.
  • 4Hanahan D,Weinberg R A. Hallmarks of cancer: the next genera- tion[J]. Ce11,2011,144(5) :646-674.
  • 5Chen D S, Mellman I. Oncology meets immunology: the cancer-im munity cycle[J]. Immunity, 2013,39 (1) : 1 - 10.
  • 6Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and loca tion of immune cells within human colorectal tumors predict clinical outcome[J]. Science, 2006,313(5795) ~ 1960-1964.
  • 7Mlecnik B, Tosolini M, Kirilovsky A, et al. Histopathologic-based prog nostic factors of eolorectal cancers are associated with the state of the 1o cal immune reaction[J]. J Clin Oncol,2011,29(6) :610-618.
  • 8Halama N,Michel S,Kloor M,et al. Localization and density of im- mune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy[J]. Cancer Res,2011,71(17) ~5670-5677.
  • 9Mlecnik B, Bindea G, Pages F, et al. Tumor immunosurveillance in human cancers[J], Cancer Metastasis Rev,2011,30(1) :5-I2.
  • 10Senovilla L,Vacchelli E,Galon J, et al. Trial watch~ Prognostic and predictive value o{ the immune in{Jltrate in eancer[J]. Oncoimmu nology,2012,1(8) : 1323-1343.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部